Skip to content

Eritoran

Drug profile

Also known as: eritoran sodium, eritoran tetrasodium

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Eritoran is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including TLR4.

  • Molecular targets: TLR4 (1 listed in DrugCentral).
  • Molecular formula: C66H126N2O19P2; molecular weight 1313.68 g/mol.

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Toll-like receptor 4TLR4unknownIC50 8.82

Chemical structure

Molecular formulaC66H126N2O19P2
Molecular weight1313.68 g/mol
CAS number185955-34-4
InChIKeyBPSMYQFMCXXNPC-PFJUCRORSA-N
PubChem CID6912404
CCCCCCCCCCCC(=O)CC(=O)N[C@H]1[C@H](OP(O)(O)=O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(O)(O)=O)[C@H](OCC[C@@H](CCCCCCC)OC)[C@H]2NC(=O)CCCCCCCCC\C=C/CCCCCC)[C@@H](O)[C@@H]1OCCCCCCCCCC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Eritoran work?

Its molecular targets in DrugCentral include TLR4.

What is the chemical formula of Eritoran?

Eritoran has the molecular formula C66H126N2O19P2 and a molecular weight of 1313.68 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications0
FormulaC66H126N2O19P2
DrugCentral ID1044
Interactive profile